Tricuspid valvulectomy.
D000818:Animals; D006328:Cardiac Catheterization; D004077:Digoxin / Q000627:therapeutic use; D004285:Dogs; D006333:Heart Failure / Q000209:etiology; D006349:Heart Valve Diseases / Q000150:complications; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D003932:Heroin; D006801:Humans; D007275:Injections, Intravenous / Q000009:adverse effects; D008297:Male; D011183:Postoperative Complications; D011552:Pseudomonas Infections / Q000150:complications; D012651:Self Medication; D013203:Staphylococcal Infections / Q000150:complications; D019966:Substance-Related Disorders / Q000150:complications; D014261:Tricuspid Valve / Q000601:surgery*; D014262:Tricuspid Valve Insufficiency / Q000601:surgery; D014690:Venous Pressure
D003932:Heroin; D004077:Digoxin